Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 10,000 shares at $129.96 ($1.3M) on 2021-04-05, disclosed to the SEC on 2021-04-06.
Open-market sale of $1.3M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.76 | 610 | $78K | 6.0% |
| 2 | $127.76 | 610 | $78K | 6.0% |
| 3 | $128.65 | 814 | $105K | 8.1% |
| 4 | $128.65 | 814 | $105K | 8.1% |
| 5 | $129.96 | 2,426 | $315K | 24.3% |
| 6 | $129.96 | 2,426 |
| $315K |
| 24.3% |
| 7 | $130.95 | 1,150 | $151K | 11.6% |
| 8 | $130.95 | 1,150 | $151K | 11.6% |
| Total | $129.71 avg | 10,000 | $1.3M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |